Imagine360 Unveils New Product To Provide Employers More Transparency
Imagine360 has launched a new product called Complete Care, which includes a pharmacy benefit solution named Imagine360Rx.
Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025?
Regulators will have their work cut out for them under a new administration that has expressed an anti-regulatory preference. Republicans next year will control the White House, Senate and House. What will it all mean for pharmacy leaders?
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Waltz Health Unveils New Solution to Lower Specialty Medication Costs
Waltz Health launched Waltz Connect on Monday. The solution supports payers and aims to lower specialty drug costs.
presented by
The PBM Model of the Future: Why Payers Are Unbundling PBM Services
Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model.
White Bagging Policies Endanger the Lives of Cancer Patients
Insurers and PBMs are increasingly implementing white-bagging policies, which require oncology practices to obtain physician-administered infusions and other medications from designated specialty pharmacies often owned by or affiliated with insurers and their PBMs.
What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis
Pharmaceutical industry observers say CVS Health’s creation of Cordavis, a new biosimilar drugs company, is part of a strategy to make its move into this market as profitable as possible.
presented by
Could QuantalX’s Device Make Managing Brain Health Easier?
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Danny Sanchez, CEO of EmpiRx Health
In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Danny Sanchez, who recently became the new CEO of EmpiRx Health, a value-based pharmacy benefit manager.
Medicare Drug Negotiation Is the Model for the Future of Drug Pricing, Abarca CEO Says
For the first time ever, CMS is preparing to negotiate prices for drugs paid for by Medicare. This has sparked a huge debate — will the creation of this taxpayer-funded drug negotiation infrastructure be a failed experiment, or will it become the standard for the future of drug pricing in this country? Jason Borschow, president and CEO of Abarca Health, says it's the latter.
Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons
Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers.
Mark Cuban’s Cost Plus Drugs Turns Focus to Employers
Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers' current pharmacy benefit offerings and provides access to Cost Plus Drugs' discounted medications.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Express Scripts Must Pay State AG $3.2M for Allegedly Overcharging for Prescriptions
Following an investigation, the AG claimed Express Scripts, “billed and obtained payment for prescription drugs from payers of workers' compensation claims in excess of amounts permitted by Massachusetts laws and regulations,” according to court documents.
With PBM satisfaction on the decline, Centene switches to Express Scripts
Centene is swapping CVS Caremark with Express Scripts. A recent survey that measured benefit leaders' satisfaction with their PBMs found that Express Scripts performed better than CVS Caremark.
States should be allowed to regulate PBMs, according to 35 state AGs advocating in Oklahoma case
A trade association for PBMs says that state PBM regulations in Oklahoma are preempted by federal ERISA and Medicare regulations.
PBM WithMe joins health navigation platform Castlight’s partner network
The company touts its personalized approach to helping patients who need the most support with medications, like those who are managing multiple health conditions.
Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies
With its ruling to maintain the status quo, the FTC has decided to take a back-seat and force independent pharmacies to fend for themselves in their on-going fight to secure access to fair prices that allow them to stay in business and continue to serve their local communities and the well-being of their patients.